Regulating effect of 17β-estradiol on osteoprotegerin and osteoclast differentiation factor expressions in osteoblasts from newborn rats
Xiong Qian
Abstract
Xiong Qian
Abstract
Osteoblasts (OB) isolated from newborn SD rats were cultured in vitro.After treatment with different concentrations of 17β-estradiol (10~(-11)-10~(-6)mol/L),the mRNA expressions of osteoprotegerin (OPG) and osteoclast differentiation factor (ODF) in OB were measured by RT-PCR.17β-estradiol increased the expression of OPG in OB with the maximal effect at the concentration of 10~(-8) mol/L.No significant difference was observed in the expression of ODF in OB with different concentrations of 17β-estradiol.The therapeutic effect of estrogen on osteoporosis appears to be related to the enhanced OPG expression in OB at physiological concentration of estrogen.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Osteoblasts (OB) isolated from newborn SD rats were cultured in vitro.After treatment with different concentrations of 17β-estradiol (10~(-11)-10~(-6)mol/L),the mRNA expressions of osteoprotegerin (OPG) and osteoclast differentiation factor (ODF) in OB were measured by RT-PCR.17β-estradiol increased the expression of OPG in OB with the maximal effect at the concentration of 10~(-8) mol/L.No significant difference was observed in the expression of ODF in OB with different concentrations of 17β-estradiol.The therapeutic effect of estrogen on osteoporosis appears to be related to the enhanced OPG expression in OB at physiological concentration of estrogen.
Key concepts: Osteoprotegerin, Internal medicine, Endocrinology, Osteoclast, Estrogen, Osteoporosis, Chemistry, In vitro